- Home
- JSPR vs HERZ Comparison
JSPR vs HERZ Comparison
Compare JSPR & HERZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JSPR
- HERZ
- Stock Information
- Founded
- JSPR 2018
- HERZ N/A
- Country
- JSPR United States
- HERZ United States
- Employees
- JSPR N/A
- HERZ N/A
- Industry
- JSPR Biotechnology: Biological Products (No Diagnostic Substances)
- HERZ Investment Managers
- Sector
- JSPR Health Care
- HERZ Finance
- Exchange
- JSPR Nasdaq
- HERZ Nasdaq
- Market Cap
- JSPR 47.6M
- HERZ 38.8M
- IPO Year
- JSPR N/A
- HERZ N/A
- Fundamental
- Price
- JSPR $2.64
- HERZ $2.49
- Analyst Decision
- JSPR Buy
- HERZ
- Analyst Count
- JSPR 12
- HERZ 0
- Target Price
- JSPR $30.78
- HERZ N/A
- AVG Volume (30 Days)
- JSPR 175.5K
- HERZ N/A
- Earning Date
- JSPR 11-06-2025
- HERZ N/A
- Dividend Yield
- JSPR N/A
- HERZ N/A
- EPS Growth
- JSPR N/A
- HERZ N/A
- EPS
- JSPR N/A
- HERZ N/A
- Revenue
- JSPR N/A
- HERZ N/A
- Revenue This Year
- JSPR N/A
- HERZ N/A
- Revenue Next Year
- JSPR N/A
- HERZ N/A
- P/E Ratio
- JSPR N/A
- HERZ N/A
- Revenue Growth
- JSPR N/A
- HERZ N/A
- 52 Week Low
- JSPR $2.27
- HERZ N/A
- 52 Week High
- JSPR $26.05
- HERZ N/A
- Technical
- Relative Strength Index (RSI)
- JSPR 34.62
- HERZ 53.17
- Support Level
- JSPR $2.58
- HERZ $2.40
- Resistance Level
- JSPR $2.87
- HERZ $2.56
- Average True Range (ATR)
- JSPR 0.12
- HERZ 0.10
- MACD
- JSPR 0.02
- HERZ 0.01
- Stochastic Oscillator
- JSPR 8.51
- HERZ 63.16
About JSPR Jasper Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
About HERZ Herzfeld Credit Income Fund Inc. Common Stock
Herzfeld Caribbean Basin Fund Inc operates as a closed-end management investment company. The company's investment objective is to obtain long-term capital appreciation. The firm offers customized discretionary account management and fund management services to individual and institutional investors. The fund invests in equity and equity-linked securities of public and private companies, including United States-based companies, whose securities are traded principally on a stock exchange in a Caribbean Basin Country. The fund's revenue source is through the dividends it receives. Its investments are geographically allocated in the United States followed by Mexico, Puerto Rico, and other countries.